AMG 193 is an MTA-cooperative PRMT5 inhibitor developed by Amgen, under clinical investigation for MTAP-deleted solid tumors. It is a leading candidate in the PRMT5 research space.
Specifications
CAS: { 2790567-82-5 }
Purity: ≥{98.6%}% (HPLC)
Stock: {577kg}
MOQ: {MOQ}（sample: 1 g）
Lead time: Samples: 3–5 days; Batch: 7–21 days
Documents: COA / HPLC / NMR / MSDS (available on request)
Physicochemical Properties
| M.Wt | 444.41 | |
| Formula | C22H19F3N4O3 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility | 10 mM in DMSO | |
| Chemical Name/SMILES | (4-Amino-1,3-dihydrofuro[3,4-c][1,7]naphthyridin-8-yl)[(3S)-3-[4-(trifluoromethyl)phenyl]-4-morpholinyl]methanone | |
As a dedicated supplier of pharmaceutical intermediates and APIs,
EOS Med CDMO offers AMG 193 for research and development use, We support scale-up production up to kilogram levels and provide full Drug Master File (DMF) documentation support. Every shipment comes with complete technical dossiers, including COA, MSDS, and analytical data (HPLC/HNMR), to ensure seamless regulatory compliance for your project.
Supply Capability
stock: In stock ·
Batch: up to 500 kg
Specifications
Synonyms: AMG-193
Target: PRMT5 (MTA-cooperative)
Research Area: MTAP-deleted cancers
Transportation Conditions: This product is a non-hazardous chemical and should be transported at room temperature. It can be stably stored for several weeks during normal transportation and customs clearance.
Storage Conditions: Short-term (days to weeks) storage at 0-4°C; long-term (months to years) storage at -20°C.
Solubility: To be determined.
Shelf Life: Over 2 years under proper storage conditions.
Pharmaceutical Preparations: To be determined.
HS Code: 2934.99.9001